Example: biology

Search results with tag "Nitrosamines"

Neutralizing Agents - ADDAPT Chemicals BV

Neutralizing Agents - ADDAPT Chemicals BV

www.addapt-chem.com

5.4 Nitrosamine formation Nitrosamines and especially N-Nitrosamines are considered to be very carcinogenic. Secondary (Alkanol)-amines are the most potent to form N-Nitrosamines. These N-Nitrosamines

  Agent, Neutralizing agents, Neutralizing, Nitrosamines

(付表1-1)環境負荷物質管理基準(自動車部品)

(付表1-1)環境負荷物質管理基準(自動車部品)

www.suncall.co.jp

Nitrosamines, selected アミン類(発ガン性ニトロソアミン類から生成の可能 性のあるもの)(指定物質) D FI Legally regulated according to German TRGS 615. Limit for all secondary Amines in volatile corrosion inhibitors, which can form carcinogenic Nitrosamines. Volatile corrosion inhibitors include papers,

  Nitrosamines

Opinion on NDELA in Cosmetic Products and Nitrosamines …

Opinion on NDELA in Cosmetic Products and Nitrosamines

ec.europa.eu

SCCS/1486/12 NDELA in Cosmetic Products and Nitrosamines in Balloons 2 About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the

  Product, Committees, Cosmetic, Balloon, Nitrosamines, In cosmetic products and nitrosamines in balloons, In cosmetic products and nitrosamines

EU - EN 71-12:2013 N-Nitrosamines and N …

EU - EN 71-12:2013 N-Nitrosamines and N …

www.intertek.com

Sparkle Vol. 724 / 19 July 2013 EU - EN 71-12:2013 – N-Nitrosamines and N-Nitrosatable Substances in Toys Has Been Published and Harmonised EN 71-12 has been published to provide test methods in support of the EU requirements for

  Substance, Nitrosamines, Nitrosamines and n nitrosatable substances, Nitrosatable

Environmental Guidelines and Regulations for Nitrosamines ...

Environmental Guidelines and Regulations for Nitrosamines ...

www.tcmda.com

1 Environmental Guidelines and Regulations for Nitrosamines: A Policy Summary Prepared for CO 2 Technology Centre Mongstad by: Dr. Noelle E. Selin Assistant Professor of Engineering Systems and Atmospheric Chemistry

  Guidelines, Regulations, Environmental, Environmental guidelines and regulations for nitrosamines, Nitrosamines

Opinion on Nitrosamines and Secondary Amines in Cosmetic ...

Opinion on Nitrosamines and Secondary Amines in Cosmetic ...

ec.europa.eu

scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. They are: the Scientific Committee on Consumer Safety (SCCS), the Scientific Committee

  Safety, Nitrosamines, Ccss

Nitrosamine Impurities Application Guide

Nitrosamine Impurities Application Guide

www.agilent.com

nitrosamines have been found in sartan drugs, a class of medications used to treat high blood pressure and heart failure, prompting recalls of angiotensin receptor blockers (ARBs)—valsartan, losartan, and irbesartan—which were contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), two carcinogenic impurities.

  Nitrosamines

Questions and answers for marketing authorisation holders ...

Questions and answers for marketing authorisation holders ...

www.ema.europa.eu

nitrosamine impurities in human medicinal products provides general guidance and recommendations on mitigating and preventing the presence of nitrosamines in human medicinal products. In this context all MAHs/Applicants of human medicinal products should work with the manufacturers of their

  Product, Human, Impurities, Medicinal, Nitrosamines, Nitrosamine impurities in human medicinal products, In human medicinal products, Human medicinal products

GENERAL CHAPTER <1469> NITROSAMINE

GENERAL CHAPTER <1469> NITROSAMINE

www.usp.org

Nov 19, 2020 · 7. TEST METHOD PERFORMANCE CHARACTERISTICS OF NITROSAMINE METHODS Lastly, the section provides recommended performance criteria for quantitative and qualitative procedures used for testing for nitrosamines. Recommended Quantitative Analytical Procedure Performance Criteria. 18. Content and rationale. Parameter

  General, Methods, Chapter, Analytical, 1964, Nitrosamines, General chapter lt 1469 gt nitrosamine

Technical Fact Sheet – N-Nitroso-dimethylamine (NDMA)

Technical Fact Sheet – N-Nitroso-dimethylamine (NDMA)

www.epa.gov

nitrosamines formed during processing; (5) using toiletry and cosmetic products such as shampoos and cleansers that contain NDMA; and (6) breathing or inhaling cigarette smoke. Workplace exposure can occur at tanneries, pesticide manufacturing plants and rubber and tire plants (ATSDR 1989, 1999). The oral route, including consumption of

  Product, Cosmetic, Nitrosamines, Cosmetic products

Nitrosamines EMEA-H-A5(3)-1490 - Information on ...

Nitrosamines EMEA-H-A5(3)-1490 - Information on ...

www.ema.europa.eu

Information on nitrosamines for marketing authorisation holders EMA/189634/2019 Page 2/5 form or are carried over during production, the impurities should normally be controlled and removed during the manufacturing process. Therefore, despite …

  Information, Marketing, Authorisation, Holder, Nitrosamines, Information on nitrosamines for marketing authorisation holders

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers …

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers …

www.ema.europa.eu

Questions and answers on “Information on nitrosamines for marketing authorisation holders” EMA/CHMP/428592/2019 Page 4/11 3. How should the risk evaluation be implemented? MAHs together with API and finished product manufacturers are required to perform risk evaluations using quality risk management principles, as outlined in ICH Q9 guideline.

  Information, Marketing, Authorisation, Holder, Nitrosamines, Information on nitrosamines for marketing authorisation holders

厚生労働省医薬・生活衛生局医薬品審査管理課長 ( 公 印 省  …

厚生労働省医薬・生活衛生局医薬品審査管理課長 ( 公 印 省 …

www.mhlw.go.jp

Assessment report:Nitrosamine impurities in human medicinal products. Questions and answers for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. FDAのガイダンス注

  Product, Human, Impurities, Medicinal, Nitrosamines, Nitrosamine impurities in human medicinal products

Procedure under Article 5(3) of Regulation EC (No) 726 ...

Procedure under Article 5(3) of Regulation EC (No) 726 ...

www.ema.europa.eu

Committee for Medicinal Products for Human Use (CHMP) Assessment report . Procedure under Article 5(3) of Regulation EC (No) 726/2004 . Nitrosamine impurities in human medicinal products . Procedure number: EMEA/H/A-5(3)/1490 . Note: Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted.

  Product, Human, Impurities, Medicinal, For human, Nitrosamines, Nitrosamine impurities in human medicinal products

Similar queries